270 related articles for article (PubMed ID: 7966623)
1. Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement.
Tsatsanis C; Fulton R; Nishigaki K; Tsujimoto H; Levy L; Terry A; Spandidos D; Onions D; Neil JC
J Virol; 1994 Dec; 68(12):8296-303. PubMed ID: 7966623
[TBL] [Abstract][Full Text] [Related]
2. Coincident involvement of flvi-2, c-myc, and novel env genes in natural and experimental lymphosarcomas induced by feline leukemia virus.
Levy LS; Lobelle-Rich PA; Overbaugh J; Abkowitz JL; Fulton R; Roy-Burman P
Virology; 1993 Oct; 196(2):892-5. PubMed ID: 8396818
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of feline leukemia virus T17: contrasting fates of helper, v-myc, and v-tcr proviruses in secondary tumors.
Terry A; Fulton R; Stewart M; Onions DE; Neil JC
J Virol; 1992 Jun; 66(6):3538-49. PubMed ID: 1316466
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of feline leukemia virus-induced multicentric lymphomas.
Athas GB; Choi B; Prabhu S; Lobelle-Rich PA; Levy LS
Virology; 1995 Dec; 214(2):431-8. PubMed ID: 8553544
[TBL] [Abstract][Full Text] [Related]
5. Insertional mutagenesis of flvi-2 in tumors induced by infection with LC-FeLV, a myc-containing strain of feline leukemia virus.
Levy LS; Lobelle-Rich PA
J Virol; 1992 May; 66(5):2885-92. PubMed ID: 1313907
[TBL] [Abstract][Full Text] [Related]
6. flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type.
Levesque KS; Bonham L; Levy LS
J Virol; 1990 Jul; 64(7):3455-62. PubMed ID: 2161948
[TBL] [Abstract][Full Text] [Related]
7. Moloney murine leukemia virus-induced lymphomas in p53-deficient mice: overlapping pathways in tumor development?
Baxter EW; Blyth K; Donehower LA; Cameron ER; Onions DE; Neil JC
J Virol; 1996 Apr; 70(4):2095-100. PubMed ID: 8642629
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis.
Fujino Y; Ohno K; Tsujimoto H
Vet Immunol Immunopathol; 2008 May; 123(1-2):138-43. PubMed ID: 18313764
[TBL] [Abstract][Full Text] [Related]
9. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
Rohn JL; Lauring AS; Linenberger ML; Overbaugh J
J Virol; 1996 Nov; 70(11):8071-80. PubMed ID: 8892932
[TBL] [Abstract][Full Text] [Related]
10. Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses.
McDougall AS; Terry A; Tzavaras T; Cheney C; Rojko J; Neil JC
J Virol; 1994 Apr; 68(4):2151-60. PubMed ID: 8138999
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of tumours from feline immunodeficiency virus (FIV)-infected cats: an indirect role for FIV?
Terry A; Callanan JJ; Fulton R; Jarrett O; Neil JC
Int J Cancer; 1995 Apr; 61(2):227-32. PubMed ID: 7705953
[TBL] [Abstract][Full Text] [Related]
12. Characterization of pal-1, a common proviral insertion site in murine leukemia virus-induced lymphomas of c-myc and Pim-1 transgenic mice.
Scheijen B; Jonkers J; Acton D; Berns A
J Virol; 1997 Jan; 71(1):9-16. PubMed ID: 8985317
[TBL] [Abstract][Full Text] [Related]
13. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
Johnson C; Lobelle-Rich PA; Puetter A; Levy LS
J Virol; 2005 Jan; 79(1):57-66. PubMed ID: 15596801
[TBL] [Abstract][Full Text] [Related]
14. A common proviral integration region, fit-1, in T-cell tumors induced by myc-containing feline leukemia viruses.
Tsujimoto H; Fulton R; Nishigaki K; Matsumoto Y; Hasegawa A; Tsujimoto A; Cevario S; O'Brien SJ; Terry A; Onions D
Virology; 1993 Oct; 196(2):845-8. PubMed ID: 8396812
[TBL] [Abstract][Full Text] [Related]
15. Moloney murine leukemia virus infection accelerates lymphomagenesis in E mu-bcl-2 transgenic mice.
Shinto Y; Morimoto M; Katsumata M; Uchida A; Aozasa K; Okamoto M; Kurosawa T; Ochi T; Greene MI; Tsujimoto Y
Oncogene; 1995 Nov; 11(9):1729-36. PubMed ID: 7478600
[TBL] [Abstract][Full Text] [Related]
16. flvi-2, a target of retroviral insertional mutagenesis in feline thymic lymphosarcomas, encodes bmi-1.
Levy LS; Lobelle-Rich PA; Overbaugh J
Oncogene; 1993 Jul; 8(7):1833-8. PubMed ID: 8390036
[TBL] [Abstract][Full Text] [Related]
17. Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
Pandey R; Ghosh AK; Kumar DV; Bachman BA; Shibata D; Roy-Burman P
J Virol; 1991 Dec; 65(12):6495-508. PubMed ID: 1658356
[TBL] [Abstract][Full Text] [Related]
18. Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors.
Rohn JL; Linenberger ML; Hoover EA; Overbaugh J
J Virol; 1994 Apr; 68(4):2458-67. PubMed ID: 8139030
[TBL] [Abstract][Full Text] [Related]
19. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats.
Levy LS; Fish RE; Baskin GB
J Virol; 1988 Dec; 62(12):4770-3. PubMed ID: 2846887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
